Macrocyclization enhances affinity of chemokine-binding peptoids
Kevin Brahm1, Julia S Wack1, Stefanie Eckes1
1Clemens-Schöpf-Institute of Organic Chemistry and Biochemistry, TU Darmstadt, Darmstadt, Germany.
Biopolymers
|December 15, 2018
Summary
Researchers developed a method to label and cyclize peptoid sequences targeting interleukin-8 (CXCL8). This macrocyclization strategy significantly enhances binding affinity for potential inflammatory disease treatments.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Molecular Biology
Background:
- Peptoids are versatile molecules capable of binding protein targets.
- Macrocyclization is a known technique to improve molecular rigidity and binding affinity.
- Interleukin-8 (CXCL8) is a key chemokine in inflammatory diseases.
Purpose of the Study:
- To develop a combined strategy for labeling and macrocyclizing peptoid sequences.
- To enhance the binding affinity of peptoids against the inflammatory chemokine CXCL8.
- To create a method applicable to various peptoid sequences.
Main Methods:
- Selection of hexameric peptoid sequences against CXCL8 using one-bead-one-compound libraries.
- On-bead macrocyclization of peptoid sequences with side-chain protecting groups.
- Tetramethylrhodamine labeling of the cyclized peptoid sequences.
Main Results:
- Successful labeling and macrocyclization of peptoid sequences targeting CXCL8.
- Macrocyclization increased the binding affinity of peptoids to CXCL8 by over an order of magnitude.
- The developed strategy is adaptable to a wide range of peptoid sequences.
Conclusions:
- The combined labeling and macrocyclization strategy effectively enhances peptoid affinity for protein targets.
- This approach offers a promising avenue for developing novel therapeutics for CXCL8-mediated inflammatory diseases.
- The method's versatility allows for broad application in peptoid-based drug discovery.
Related Concept Videos
Affinity and Avidity
39.0K
Overview
39.0K
The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
The Equilibrium Binding Constant and Binding Strength
10.0K
10.0K
Electron Affinity
43.3K
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.3K
Affinity Chromatography
3.0K
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
3.0K
Ligand Binding Sites
15.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K


